Chikungunya vaccination information
Chikungunya vaccinations authorised in the UK including updates on recent possible serious adverse events in older people in post marketing surveillance
Changes to the country information pages: dengue vaccine recommendations
NaTHNaC has reviewed and updated the dengue country-specific information and vaccine recommendations
Falsified antibiotics reported in WHO African Region
Falsified HEALMOXY (Amoxicillin) identified in Cameroon and Central African Republic
Increase in drug resistant gonorrhoea reported in UK travellers
Travelling abroad? Be aware of your risk of sexually transmitted infections and protect yourself for a safe and enjoyable trip
Mpox outbreak in Africa: clade I mpox virus infection
Mpox outbreak continues to meet the WHO criteria of a public health emergency of international concern (PHEIC)
'Getting to grips with Japanese encephalitis' webinar, Thursday 8 May 2025
Registration is now open for our next 'Getting to Grips' webinar of 2025, 'Getting to grips with Japanese encephalitis'
Gastrointestinal disorders
Information on pre-travel preparation, tips to stay healthy abroad and links to useful resources for travellers with gastrointestinal disorders
Travel with a stoma
Information on pre-travel preparation, tips to stay healthy abroad and links to useful resources for travellers with a stoma
Ebola disease in Uganda
On 26 April 2025, the Ugandan Ministry of Health declared the outbreak of Ebola disease over
RCN and NaTHNaC Joint Travel Health Conference 2025
Recording of the 8th Royal College of Nursing (RCN) and NaTHNaC joint Travel Health Conference on Saturday 22 March 2025 is now available online
Invasive meningococcal disease reported in Umrah pilgrims in 2025
If you are planning to visit Saudi Arabia for Hajj 1446H or Umrah in 2025, make sure you are vaccinated
Hajj 1446H and Umrah update: 2025
Information for pilgrims planning to perform Hajj or Umrah in 2025
Mpox in Australia
On 13 May 2025, Australia reported their first case of clade Ib mpox in an individual who had travelled overseas. Please see our Topics in Brief article for further details on mpox.
cVDPV2 in Burkina Faso
As of 14 May 2025, one case of circulating vaccine-derived poliovirus type 2 (cVDPV2) has been reported from Fada, with onset of paralysis on 30 March 2025. This is the first human case reported in Burkina Faso since 2023. Please see our Topics in Brief article for further details on polio.
cVDPV2 in Papua New Guinea
As of 16 May 2025, two cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) have been reported from Lae, Morobe Province. Please see our Topics in Brief article for further details on polio.
Mpox in India
On 4 May 2025, India retrospectively reported nine cases of mpox due to clade Ib mpox, detected between December 2024 and March 2025. This brings the country's total to 10 cases. All cases reported recent history of travel to countries in the Gulf or contact with travellers from those countries. Please see our Topics in Brief article for further details on mpox.
Kandy
Gampaha
Chikungunya in Sri Lanka
As of 14 March 2025, a total of 173 chikungunya cases were reported in Colombo, Gampaha and Kandy (22 cases in November and December 2024, and 151 cases during 2025). Please see our Topics in Brief article for further details on chikungunya.
MERS-CoV in Saudi Arabia
Between 1 March and 21 April 2025, the Ministry of Health of the Kingdom of Saudi Arabia reported nine cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection. Two of these cases died. Among the nine cases, seven cases were identified in Riyadh, including six health care workers who acquired the infection caring for an infected patient. Please see our Topics in Brief article for further details on MERS-CoV.
Oropouche virus disease in Brazil
As of 8 May 2025, a total of 9,416 confirmed cases of Oropouche virus disease, with one death currently under investigation, have been reported in Brazil for 2025. Please see our Topics in Brief article for further details on Oropouche virus disease.
Chikungunya in Réunion
As of 12 May 2025, over 47,500 confirmed chikungunya cases and over 170,000 consultations for suspected chikungunya have been reported since August 2024. In 2025, a total of 340 hospital admissions, with 12 deaths linked to chikungunya, have been reported. All municipalities have reported cases, with southern areas most affected, particularly Le Tampon. The French National Authority for Health (HAS) have withdrawn vaccination in people over 65 years whilst a small number of possible adverse reactions in this age group are investigated. Please see our Topics in Brief article for further details on chikungunya.
Chikungunya in Mayotte
As of 9 May 2025, a total of 139 chikungunya cases, with five hospital admissions, have now been reported in Mayotte in 2025. This total includes 29 imported cases, 58 locally acquired cases and 52 cases currently under investigation. Please see our Topics in Brief article for further details on chikungunya.
Nipah virus in India
As of 9 May 2025, one case of Nipah virus disease has been reported from Malappuram district, Kerala during 2025. Please see our Topics in Brief article for further details on Nipah virus disease.
